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The presence and characteristics were investigated of vancomycin-resistant enterococci (VRE) in pigs in
Thailand. A total of 179 rectal swabs were collected aseptically from suckling pigs, fattening pigs and
breeding sows on four commercial farms located in Central Thailand. VRE with minimum inhibitory
concentrations ranging from 8 mg/mL to 16 mg/mL were detected in 43 of 179 pigs (an overall prevalence
rate of 24%). VRE carriers were identiﬁed in 12 of 61 (19.7%) suckling pigs, 15 of 60 (25%) fattening pigs
and 16 of 58 (27.6%) breeding sows, respectively. Enterococcus gallinarumwas the most prevalent species
for VRE in all age groups, followed by the detection of Enterococcus casseliﬂavus. All of the isolates were
susceptible to teicoplanin. A large proportion of VRE isolates showed resistance to tetracycline (86.5%),
erythromycin (61.5%), ampicillin (53.8%), chloramphenicol (34.6%) and ciproﬂoxacin (32.7%). Resistance
to ampicillin was more prevalent in E. gallinarum isolates than in E. casseliﬂavus isolates. The results of
this study indicate that VRE isolates of pigs are of the VanC phenotype and commonly exhibit multiple
drug resistance. Different antimicrobial susceptibility is present between VanC species, while
E. gallinarum is less susceptible than E. casseliﬂavus.
Copyright © 2016, Kasetsart University. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Enterococci are ubiquitous, Gram-positive, catalase-negative,
facultative-anaerobic bacteria and while they inhabit humans and
animals and present as a part of the normal intestinal ﬂora (Noble,
1978), they are now recognized as one of the leading causes of
hospital-associated infections (Hidron et al., 2008). Many infections
with enterococci are life-threatening and can be difﬁcult to treat,
due to their resistance to several antimicrobials (Huycke et al.,
1998). Of particular concern has been the emergence of strains
with resistance to glycopeptides. Vancomycin and teicoplanin are
the glycopeptide antibiotics currently in use for the treatment of
Gram-positive bacterial infections (Murray, 2000). Vancomycin-
resistant enterococci (VRE) are typically multidrug-resistant and
treatment options are signiﬁcantly limited. Moreover, certain VREProduction and hosting by Elsevgenotypes have the potential to transfer the resistant genes to the
more virulent Gram-positive pathogen, Staphylococcus aureus
(Noble et al., 1992).
VRE were ﬁrst reported in the late 1980s (Leclercq et al., 1988).
Since then, VRE have been detected worldwide. In the United
States, there was a 20-fold increase in VRE infection rates within a
5-year period and the percentage of VRE identiﬁed from patients in
the intensive care unit with nosocomial infections was 28.5% in
2003 (National Nosocomial Infections Surveillance, 2004). In
Europe, a high frequency of VRE has been reported among food
animals, retail meats and non hospitalized people (Bager et al.,
1997; Bonten et al., 2001). It was found that the use of avoparcin
(a glycopeptide analogue) during livestock production was an
important factor for the emergence of VRE (Bager et al., 1997). Due
to the possible transmission of VRE and their resistant genes from
farm animals to humans, a ban was enforced throughout the Eu-
ropean Union on the use of avoparcin (Casewell et al., 2003). A
study that followed the change resulting from the ban found a
decrease in the prevalence of VRE in farm animals (Bager et al.,ier B.V. This is an open access article under the CC BY-NC-ND license (http://
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pean countries (Aarestrup, 2000). It has been hypothesized that
continued use of other antibiotics in animal husbandry is one
important factor for the persistence of VRE, since co-selection for
resistant genes located on the same genetic element can occur
(Aarestrup, 2000). In the United States, avoparcin has never been
permitted for use with food animals, but VRE have been recently
isolated from pigs (Donabedian et al., 2010). Therefore, avoparcin
may not be an absolute factor for the development of vancomycin
resistance in animals.
In Thailand, VRE have been isolated from patients, companion
animals, frozen foods and environmental water (Chalermchaikit
et al., 2005; Tansuphasiri et al., 2006; Thongkoom et al., 2012). In
addition, in the 1990s, contamination of VRE in the poultry prod-
ucts exported to Japan was ﬁrst detected (Ike et al., 1999) and
resulted in severe economic losses. In order to implement an
effective prevention and control program for VRE, all potential
sources should be investigated. Although antimicrobials are
commonly used in swine production, there has been no report of
VRE detection from pig farms in Thailand. The goals of this study
were: 1) to isolate VRE from pigs in Central Thailand; 2) to identify
the species; and 3) to characterize antimicrobial susceptibility
proﬁles.Materials and methods
Pig farms, antimicrobial use and collection of samples
Sample collection was performed during 2011 in four commer-
cial pig farms, located in Lopburi, Saraburi, Suphanburi and
Ratchaburi provinces, Central Thailand. The farm in each province
had a sow herd size of about 500, 400, 1200 and 4000 breeding
sows, respectively. Data on antimicrobial use in the pig farms were
also collected. In all farms, antimicrobial agents were used as feed
supplements for swine disease control. The use of antimicrobials
was under strict veterinary supervision and the speciﬁc types of
antimicrobials used were penicillin (amoxicillin), tetracycline
(chlortetracycline), macrolide (tilmicosin and valosin), poly-
peptides (colistin), pleuromutilin (tiamulin) and phosphonic acid
(fosfomycin).
Rectal swabs were collected aseptically from randomly sampled
pigs of different age groups: suckling pigs, fattening pigs and
breeding sows. Fecal samples were preserved in Cary-Blair medium
and transported to the laboratory on ice and processed within 18 h.Isolation of vancomycin-resistant enterococci from fecal samples
The protocol for screening VRE in pigs has been described
elsewhere (Pimarn et al., 2011). Fecal samples (approximately 0.5 g)
were subjected to a 10-fold serial dilution with buffered peptone
water. Diluted fecal slurries were then inoculated onto bile-esculin
azide (BEA) agars (Becton Dickinson and Company; Franklin Lakes,
NJ, USA) supplemented with 6 mg/mL vancomycin (SigmaeAldrich;
St. Louis, MO, USA). BEA with vancomycin (BEAV) was used as the
VRE selective agar, as recommended by Clinical and Laboratory
Standards Institute (2011). After incubation at 37 C for 48 h, cul-
ture plates were examined for typical enterococcal colonies. From
each sample, colonies with a brown to black halo from the BEAV
plates were isolated and then tested for catalase and Gram stain. An
isolate demonstrating Gram-positive cocci and negative for catalase
was prepared as stock culture in Luria-Bertani broth with 20%
glycerol and stored at 80 C until subsequent identiﬁcation and
characterization of VRE.Identiﬁcation of vancomycin-resistant enterococci isolates
The genus identity of presumptive VRE isolates was conﬁrmed
by testing on a bile-esculin reaction, 6.5% salt-tolerance test, me-
dium for growth at 45 C, L-pyrrolidonyl-b-naphthylamide (PYR)
and leucine-b-naphthylamide (LAP) tests (Facklam and Elliott,
1995). The PYR and LAP tests were performed, according to the
manufacturer's instructions (Oxoid Ltd.; Hampshire, UK). Identiﬁ-
cation to the species level followed the procedures and biochemical
key for Enterococcus spp., as previously described (Facklam and
Elliott, 1995; Teixeira et al., 2007). Any isolates with ambiguous
identiﬁcationwere conﬁrmed by species-speciﬁc polymerase chain
reaction (PCR) analysis (Jackson et al., 2004). Enterococcus faecalis
ATCC 14506, Enterococcus gallinarum ATCC 49573 and Enterococcus
casseliﬂavus ATCC 25788 were included as reference strains.
Antimicrobial susceptibility testing
Levels of vancomycin resistance were determined using mini-
mal inhibitory concentration (MIC) testing with the agar dilution
technique (Clinical and Laboratory Standards Institute, 2011).
Brieﬂy, the MIC testing was carried out on Mueller-Hinton agars
(Neogen Corporation; Lansing, MI, USA) containing serial two-fold
dilutions (1e128 mg/mL) of vancomycin. The agar plates were then
spot inoculated with 1  104 colony-forming units per spot using a
microplanter and incubated at 37 C for 24 h. E. faecalis ATCC 29212
and 51299 were used as sensitive and resistant controls, respec-
tively. The Clinical and Laboratory Standards Institute (2011)
breakpoints for vancomycin susceptibility are 4 mg/mL or less for
susceptible, 8e16 mg/mL for intermediate resistance and 32 mg/mL
and above for resistant. Strains with intermediate resistance are
also clinically signiﬁcant, so in this paper, isolates with vancomycin
MICs of 8 mg/mL or more were regarded as VRE.
VRE isolates were tested for susceptibility to a selection of an-
timicrobials using the KirbyeBauer disc diffusion method (Bauer
et al., 1966). The antimicrobials consisted of 13 antimicrobial
agent discs (Oxoid Ltd.; Hampshire, UK) of teicoplanin (30 mg),
ampicillin (10 mg), tetracycline (30 mg), ciproﬂoxacin (5 mg), nitro-
furantoin (300 mg), rifampin (5 mg), chloramphenicol (30 mg), qui-
nupristinedalfopristin (15 mg), linezolid (30 mg), fosfomycin
(200 mg), streptomycin (300 mg), gentamicin (120 mg) and eryth-
romycin (15 mg). Staphylococcus aureus ATCC 25923 was used as a
control strain and inhibition zones were evaluated following the
guidelines of Clinical and Laboratory Standards Institute (2011).
Isolates were classiﬁed as multidrug resistant based on the occur-
rence of resistance to more than two antibiotics.
Statistical analysis
Fisher's exact and Student's t tests were undertaken using the
Quickcals Program (GraphPad Software Inc.; La Jolla, CA, USA). The
results were deemed statistically signiﬁcant if p < 0.05.
Results
Species distribution and prevalence rates of vancomycin-resistant
enterococci in pigs of different age groups
In total, 179 fecal samples were collected from 61 suckling pigs,
60 fattening pigs and 58 breeding sows. Using isolation with the
VRE screening agars and identiﬁcation the genus level, 71 pre-
sumptive isolates were detected. These isolates were each identi-
ﬁed to the species level and the levels of vancomycin resistance
were determined by the MIC method. With biochemical pheno-
typing and PCR analysis, 44 isolates were identiﬁed as E. gallinarum,
Table 2
Prevalence of antimicrobial resistance in vancomycin-resistant Enterococcus galli-
narum (VREg) and E. casseliﬂavus (VREc) isolated from pigs.
Antimicrobial agent Number (n) of isolates resistant
to antimicrobials (%)
Total (n ¼ 52)
VREg (n ¼ 40) VREc (n ¼ 12)
Tetracycline 36 (90) 9 (75) 45 (86.5)
Erythromycin 24 (60) 8 (66.7) 32 (61.5)
Ampicillin 26 (65)a 2 (16.7)a 28 (53.8)
Chloramphenicol 13 (32.5) 5 (41.7) 18 (34.6)
Ciproﬂoxacin 16 (40) 1 (8.3) 17 (32.7)
Gentamicin 7 (17.5) 1 (8.3) 8 (15.4)
Quinupristinedalfopristin 6 (15) 1 (8.3) 7 (13.5)
Linezolid 4 (10) 2 (16.7) 6 (11.5)
Streptomycin 5 (12.5) 1 (8.3) 6 (11.5)
Rifampin 2 (5) 3 (25) 5 (9.6)
Fosfomycin 1 (2.5) 1 (8.3) 2 (3.8)
Nitrofurantoin 1 (2.5) 0 1 (1.9)
a Signiﬁcantly different (Fisher's exact test, p ¼ 0.0066).
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phoeniculicola. E. gallinarum and E. casseliﬂavus isolates exhibited
vancomycin MICs ranging from 2 to 16 mg/mL and 4e16 mg/mL,
respectively. ThemeanMIC in E. gallinarum (8.3) was higher than in
E. casseliﬂavus (6.5) isolates, with statistical signiﬁcance (p < 0.05).
In total, 52 isolates with MICs ranging from 8 to 16 mg/mL were
classiﬁed as VRE and further characterized.
The VRE carriers were identiﬁed in 12 of 61 (19.7%) suckling
pigs, 15 of 60 (25%) fattening pigs and 16 of 58 (27.6%) breeding
sows, as shown in Table 1. VRE was detected in 43 of the 179 pigs,
accounting for an overall prevalence rate of 24%. The occurrence of
VRE between age groups was not statistically signiﬁcant. When the
VRE detection rates were categorized by species, 17.9% of pigs were
found to harbor vancomycin-resistant E. gallinarum (VREg) and 5%
were positive for vancomycin-resistant E. casseliﬂavus (VREc). VRE
carriers of the two different species were detected in 2 (1.1%)
breeding sows. VREg was more prevalent in pigs than VREc
(p ¼ 0.0002). This trend was observed in all age groups.Antimicrobial resistance rates of vancomycin-resistant enterococci
The activities of 13 different antimicrobials were tested on VRE.
All isolates were susceptible to teicoplanin. Table 2 shows the rates
of antimicrobial resistance in the 52 VRE isolates. One (1.9%) and
two (3.8%) isolates displayed resistance to nitrofurantoin and fos-
fomycin, respectively. Seven (13.5%) isolates were resistant to qui-
nupristinedalfopristin, 11.5% were resistant to linezolid and 9.6%
were resistant to rifampin. For susceptibility to aminoglycosides,
eight (15.4%) isolates exhibited high-level resistance to gentamicin
and 6 (11.5%) exhibited high-level resistance to streptomycin. A
large proportion of VRE isolates showed resistance to tetracycline
(86.5%), erythromycin (61.5%), ampicillin (53.8%), chloramphenicol
(34.6%) and ciproﬂoxacin (32.7%).
The antimicrobial resistance frequency of VREg and VREc was
also analyzed. Surprisingly, resistance to ampicillin was more
prevalent in VREg (65%) than in VREc (16.7%) isolates (p ¼ 0.0066).
Forty percent of VREg isolates were resistant to ciproﬂoxacin, and
prevalence rates of 8.3%were found among VREc isolates. Statistical
analysis of these ciproﬂoxacin-resistant rates showed no signiﬁcant
differences.Antimicrobial resistance proﬁles of vancomycin-resistant
enterococci
Table 3 shows the antimicrobial resistance patterns of VRE and
their fecal samples of origin. There was only one VRE isolate sus-
ceptible to all the antimicrobials tested. A degree of resistance with
2e5 antimicrobials was found in the majority of VRE isolates. The
detection rates of multidrug-resistant VRE in suckling pigs,
fattening pigs and breeding sows were 84.6%, 94.1% and 90.9%,
respectively. Multiple resistant strains were detected in 47 (90.4%)
of the 52 isolates.Table 1
Species distribution and prevalence rates of vancomycin-resistant enterococci (VRE) in p
Species distribution pattern Number (n) of pigs positive for VRE (%)
Suckling pig (n ¼ 61) Fatten
E. gallinarum 9 12
E. casseliﬂavus 3 3
E. gallinarum and E. casseliﬂavus 0 0
Total 12 (19.7) 15 (25
a Signiﬁcantly different (Fisher's exact test, p ¼ 0.0002).When antimicrobial resistant patterns were analyzed, correla-
tions among resistant phenotypes were found. All strains with
streptomycin resistance were also resistant to erythromycin. In
addition, the combination of resistant characters,
TEeEeAMPeCIPeC, was common in isolates with multiple resis-
tance to 5 or more antimicrobials and detected in 8 of the 12 iso-
lates. The resistant phenotypes, TEeE, TEeAMP, TEeEeAMP and
TEeEeC, were found in 28, 25, 16 and 15 isolates, respectively.Discussion
Vancomycin resistance in enterococci can be acquired or can be
intrinsic. Two main types of acquired vancomycin resistance, VanA
and VanB, have been described (Courvalin, 2005). The VanA
phenotype is characterized by high-level (MIC,  64 mg/mL),
transferable resistance to both vancomycin and teicoplanin, while
variable levels of resistance to vancomycin and susceptibility to
teicoplanin are the characteristics of the VanB phenotype. The VanB
phenotype is also considered to be transferable. The VanC pheno-
type appears to be an intrinsic property of E. gallinarum and
E. casseliﬂavus and is a low level of vancomycin resistance
(Courvalin, 2005). VanA, VanB and VanC phenotypes are mediated
by vanA, vanB and vanC gene clusters, respectively. Since Van
phenotypes are different in their transferability and susceptibility,
the status of the Van type in clinical settings and more broadly is
important epidemiologic data for VRE control.
In this study, the prevalence of VRE colonization in pigs and
their microbiological characteristics were reported. Forty-three out
of 179 (24%) pigs were found to harbor VRE. This VRE detection rate
is higher than previously reported by Bustamante et al. (2003) in
Costa Rica where a similar protocol for VRE isolation was used and
showed a VRE prevalence rate of 11%. Identical vancomycin con-
centrations but different media in the current study protocol were
used and this might explain the different detection rates. The directigs of different age groups.
Total (n ¼ 179)
ing pig (n ¼ 60) Breeding sow (n ¼ 58)
11 32 (17.9)a
3 9 (5)a
2 2 (1.1)
) 16 (27.6) 43 (24)
Table 3
Antimicrobial resistant patterns of vancomycin-resistant enterococci (VRE) and their fecal samples of origin.
Degree of antimicrobial
resistance
Number (n) of VRE resistant to antimicrobials Total
n ¼ 52
Resistant patterns (number of isolates > 1)
Suckling pig
(n ¼ 13)
Fattening pig
(n ¼ 17)
Breeding sow
(n ¼ 22)
1 1 2 1 4 TE (2), RD, AMP
2 3 4 5 12 TEeE (3), TEeAMP (4), TEeCN (2), TEeC,
TEeLZD, EeS
3 5 4 3 12 TEeEeAMP (2), TEeEeC, TEeEeCN (2),
TEeEeQD (2), TEeAMPeCIP,
TEeAMPeLZD, TEeAMPeQD, TEeCIPeCN,
EeCeCIP,
4 1 3 7 11 TEeEeAMPeC (2), TEeEeAMPeS, TEeEeAMPeCIP, TEeEeCeFOS, TEeEeC
eRD, TEeAMPeCeRD,
TEeAMPeCIPeRD, TEeCIPeLZDeFOS,
EeAMPeCIPeQD, EeAMPeSeQD
5 1 2 5 8 TEeEeAMPeCeCIP (4), TEeEeAMPeCNeS,
TEeEeCeRDeLZD, TEeEeCeCIP-CN,
TEeEeAMPeCIPeS
6 0 2 0 2 TEeEeAMPeCeCIPeLZD, TEeEeAMPeCeCIPeQD
7 1 0 0 1 TEeEeAMPeCeCIPeCNeS
8 0 1 0 1 TEeEeAMPeCeCIPeFeQDeLZD
Total multidrug-resistant
isolates (%)
11 (84.6) 16 (94.1) 20 (90.9) 47 (90.4)
TE ¼ tetracycline; E ¼ erythromycin; AMP ¼ ampicillin; C ¼ chloramphenicol; CIP ¼ ciproﬂoxacin; CN ¼ gentamicin; S ¼ streptomycin; LZD ¼ linezolid;
QD ¼ quinupristinedalfopristin; RD ¼ rifampin; FOS ¼ fosfomycin; and F ¼ nitrofurantoin.
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by Clinical and Laboratory Standards Institute (2011) and is
commonly used in laboratories as a method of VRE screening from
human stool specimens (Gambarotto et al., 2000). The current re-
sults indicate that the method is applicable to swine fecal samples.
E. gallinarum and E. casseliﬂavus were the two species identiﬁed
among VRE isolates. These VRE strains exhibited vancomycin
resistance with MICs of 8e16 mg/mL and neither were resistant to
teicoplanin. Accordingly, the VRE isolates of pigs were classiﬁed to
the VanC phenotype. However, a strain of E. gallinarum carrying
vanB genotype has been reported (Mahony et al., 2010). The current
study also investigated the presence of the vanB gene using PCR
analysis (data not shown). No vanB E. gallinarum strains were
detected. Intrinsic resistance is widely accepted as having a mini-
mal potential for horizontal transfer. The possibility of dissemina-
tion of vancomycin resistance from pigs via the genetic spread is
thus low. In addition, there was a signiﬁcant difference in species
distribution, in which VREg was more prevalent in pigs than VREc.
Consistent with this ﬁnding, the same pattern was found in the
studies of humans (Gambarotto et al., 2000) and of chickens (Jung
et al., 2007). This could be explained by the fact that E. casseliﬂavus
is generally regarded as one of the plant-associated enterococci
that can colonize animal intestines and vancomycin resistance is
uncommon (Müller et al., 2001).
The phenotype of VRE of pigs in many European countries is
mainly VanA and the emergence of this acquired-resistant type has
been linked to the use of avoparcin (Bager et al., 1997). Avoparcin
has been prohibited in farm animals in Thailand and its dis-
continued use may be an explanation for the absence of acquired
vancomycin resistance in the current study. A predominance of
VanC strains among VRE from pigs has also been reported in a
Korean study (Seo et al., 2005). The study found that 56 out of 274
enterococcal isolates from pigs were VRE (MIC: 4e8 mg/mL) and all
of them were identiﬁed as E. gallinarum and E. casseliﬂavus. How-
ever, a higher MIC level was observed among the isolates in the
current study.
Multi-drug resistance among vancomycin-resistant Entero-
coccus faecium isolates has been well described (Garcia-Migura
et al., 2005). However, there is limited data on antimicrobial
resistance among VREg and VREc strains. In the VRE isolates of pigs,multiple resistances were common. Multi-drug resistant VRE were
detected in high percentages in all age groups. In addition, the
majority of isolates was resistant to tetracycline, erythromycin,
ampicillin, chloramphenicol and ciproﬂoxacin. The occurrence and
emergence of antimicrobial resistance in a population are strongly
correlated with antimicrobial usage (van den Bogaard et al., 2000).
Although additional studies will be needed to clarify the relation-
ship between antimicrobial usage and resistance, the occurrence of
tetracycline and ampicillin resistancesmight be due to thewide use
of chlortetracycline and amoxicillin in pig farms. The use of tylosin
has been associated with the high prevalence of resistance to
erythromycin (van den Bogaard et al., 2000). Tylosin has not been
used in pigs and it is possible that the use of other macrolides is
responsible for the occurrence of erythromycin resistance. The
observed high prevalence of resistances to chloramphenicol and
ciproﬂoxacin could not be explained by a high usage, since chlor-
amphenicol and ciproﬂoxacin are no longer used in pig farms.
However, it could not be excluded that antimicrobial usage in the
past has resulted in persistence of resistance. Another explanation
might be as a result of genetic linkage and cross selection. In this
study, 94% of chloramphenicol-resistant VRE isolates were
concurrently resistant to tetracycline. This correlated with the
ﬁnding that the genes encoding chloramphenicol resistance are
often located on the same plasmid as the genes for tetracycline
resistance (Nijsten et al., 1996).
In addition to vancomycin resistance, ampicillin resistance was
more prevalent in E. gallinarum isolates than in E. casseliﬂavus
isolates. Distinction between the antimicrobial susceptibility of
E. faecium and E. faecalis has been documented (Butaye et al., 2001).
However, data on the antimicrobial susceptibility among VanC
species are limited. In the study of chicken isolates, E. gallinarum
strains were more frequently resistant to antimicrobials than
E. casseliﬂavus strains (Jung et al., 2007). The current data from pig
isolates was consistent with this ﬁnding.
Most human VRE infections have been caused by E. faecium and
E. faecaliswhich commonly display the VanA and VanB phenotypes
(Mazuski, 2008). Although VanC species have been found to infect
humans sporadically, causes of serious invasive infections,
including endocarditis and meningitis, have been reported (Toye
et al., 1997). The epidemiology of VRE infections in Thailand has
C. Pruksakorn et al. / Agriculture and Natural Resources 50 (2016) 199e203 203been described as the predominant phenotype of VanB (Nilgate
et al., 2003; Thongkoom et al., 2012). In the current study, no VRE
strains of E. faecium and E. faecaliswere recovered in pigs. Based on
the current ﬁndings, a link between the presence of VRE in pigs and
human infections could not be proposed. However, the importance
of pigs as a possible reservoir for the transfer of VanC-type
enterococci to healthy humans via the food chain could not be
excluded. A survey sampling pork in Central Thailand detected
contamination of VRE, in which E. gallinarum accounted for the
majority (67%) of isolated species (Chalermchaikit et al., 2008). In
addition, E. gallinarum and E. casseliﬂavus have been found as
commensals of the human intestinal tract (Toye et al., 1997). A
study in France showed a predominance of VanC strains in meat
products, including pork, correlated with the occurrence of VRE in
non hospitalized people (Gambarotto et al., 2001). Therefore,
additional research on healthy subjects will help to determine the
relevance of pigs as a potential VRE reservoir for human coloniza-
tion. Furthermore, the resistant characters, TEeEeAMPeCeCIP,
TEeEeC and TEeEeAMP, may be used as a predominantly resistant
phenotype of pigs.
In summary, VRE isolates of pigs were characterized as the VanC
phenotype. These strains are multidrug resistant and show species
differences in antimicrobial susceptibility. Although the potential
for horizontal gene transfer is low, the transmission risk of the VanC
strains to humans could not be excluded.Conﬂict of interest
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